Negative article by CNBC that came out an hour ago is the reason for the panic sale. I bought another 500 shares at $9.20. Usually gaps up on Fri.
Quite the scare article. I'm surprised that CNBC even publishes articles from hedgers who are spooking people because they are short on a stock. Pretty interesting to read that the head of Tourbillon used to work for SAC Capital Advisors; a company notorious for these same tactics. In fact, SAC was indicted for insider trading. Federal prosecutors saying that SAC is “a veritable magnet of market cheaters”. Now this 'rising star' is up to his old tricks at a new shop.
I'll stick with a billionaire pioneer in Mann rather than a 35 year old wannabe hotshot. This article is clear in it's intentions, and is littered with false claims.
Will be interesting to see how this all pans out. I'm holding for the long run.
0
Quote Originally Posted by dbuc1:
Negative article by CNBC that came out an hour ago is the reason for the panic sale. I bought another 500 shares at $9.20. Usually gaps up on Fri.
Quite the scare article. I'm surprised that CNBC even publishes articles from hedgers who are spooking people because they are short on a stock. Pretty interesting to read that the head of Tourbillon used to work for SAC Capital Advisors; a company notorious for these same tactics. In fact, SAC was indicted for insider trading. Federal prosecutors saying that SAC is “a veritable magnet of market cheaters”. Now this 'rising star' is up to his old tricks at a new shop.
I'll stick with a billionaire pioneer in Mann rather than a 35 year old wannabe hotshot. This article is clear in it's intentions, and is littered with false claims.
Will be interesting to see how this all pans out. I'm holding for the long run.
Are you just holding on for now? What price are you planning on selling some off at?
Holding all now. None sold. Not worth selling at this PPS. I see nothing but positive going forward. You have product making center in US and Europe. You have a partner for an approved cutting edge drug that has global prescence. Its worth much more then PPS reflecting. So many games are played with this stock.
My sell price undetermined at this time
0
Quote Originally Posted by mikebball3289:
Are you just holding on for now? What price are you planning on selling some off at?
Holding all now. None sold. Not worth selling at this PPS. I see nothing but positive going forward. You have product making center in US and Europe. You have a partner for an approved cutting edge drug that has global prescence. Its worth much more then PPS reflecting. So many games are played with this stock.
I want to state though I expected so much more price wise from this stock after the catalysts of positive Adcom, FDA approval and Partner. The price per share has definitely underperformed and is being held in check. The owners or the number of short shares of the stock still continue to manipulate the price. Read any message board and the price baffles so many people.
0
I want to state though I expected so much more price wise from this stock after the catalysts of positive Adcom, FDA approval and Partner. The price per share has definitely underperformed and is being held in check. The owners or the number of short shares of the stock still continue to manipulate the price. Read any message board and the price baffles so many people.
I think they are manipulating the share price to collect the option premiums. Look at the call options volume for Friday expiry. If the stock finishes under 9 big money lost in premiums.
0
I think they are manipulating the share price to collect the option premiums. Look at the call options volume for Friday expiry. If the stock finishes under 9 big money lost in premiums.
Yeah Fire. Its a sick game. I'll just hold on to all my shares. I don't see anything but good news here. I cant control the games. Not selling when things are heading in right direction. Sanofi is a great partner for this.
0
Yeah Fire. Its a sick game. I'll just hold on to all my shares. I don't see anything but good news here. I cant control the games. Not selling when things are heading in right direction. Sanofi is a great partner for this.
The partnership news was pretty weak as it does nothing for the stock price short term until they can show revenues/sales. Most shareholders were hoping for a buyout but current market cap was already $3.2billion so asking for a buyout of say $5-6Billion would be stretching it for an unproven drug. Partnership was the only way to go for MNKD as it probably could not get the price it wanted for a buyout. Long term this stock has a huge upside if you believe in the product. Maybe get back in this stock in the beginning of 2015 as they plan to release Afreeza in the US in the first quarter of 2015.
Mayweather bet 450000 on
0
The partnership news was pretty weak as it does nothing for the stock price short term until they can show revenues/sales. Most shareholders were hoping for a buyout but current market cap was already $3.2billion so asking for a buyout of say $5-6Billion would be stretching it for an unproven drug. Partnership was the only way to go for MNKD as it probably could not get the price it wanted for a buyout. Long term this stock has a huge upside if you believe in the product. Maybe get back in this stock in the beginning of 2015 as they plan to release Afreeza in the US in the first quarter of 2015.
The price action on this stock is unexplainable. read any message board you want. Completely manipulated. All positive news. I'm back to even on this play with all my adds. I've added in the 4s/5s and has high as 10s.
If it get pummeled much more I'll add again.
I will WIN.
0
The price action on this stock is unexplainable. read any message board you want. Completely manipulated. All positive news. I'm back to even on this play with all my adds. I've added in the 4s/5s and has high as 10s.
MannKind got a raw deal on the partnership, hence why the stock is doing so terribly:
What seems to be the big kicker here is the split in profits. Sanofi
will retain 65% of the profits, and MannKind will receive 35% of the
profits, and they will share on that basis in the losses as well. The
agreement also shows that Sanofi agreed to advance to MannKind its share
of the collaboration’s expenses with a maximum limit of $175 million.
Thats a garbage deal right there. And there is more, according to that article: MannKind gets an upfront payment of $150 million from Sanofi. It is also
set to receive milestone payments of up to $775 million, but those
milestone payments are dependent upon specific regulatory and
development targets, and then they are dependent upon sales thresholds.
In short, the devil is in the details.
Milestone payments, meaning not guaranteed payments.
The market is clearly forecasting that MannKind is not maximizing its
potential in this deal. As of the end of March, MannKind had accumulated
net loss carryforwards that has reached a total of almost $2.35
billion.
And add in the massive net loss caryforward loss of $2.35 billion.
Add it all up, and its not surprising this is not doing well. Not saying you wont make $$$$ at the end of the day, but its not all as great as it looks on paper.
MannKind got a raw deal on the partnership, hence why the stock is doing so terribly:
What seems to be the big kicker here is the split in profits. Sanofi
will retain 65% of the profits, and MannKind will receive 35% of the
profits, and they will share on that basis in the losses as well. The
agreement also shows that Sanofi agreed to advance to MannKind its share
of the collaboration’s expenses with a maximum limit of $175 million.
Thats a garbage deal right there. And there is more, according to that article: MannKind gets an upfront payment of $150 million from Sanofi. It is also
set to receive milestone payments of up to $775 million, but those
milestone payments are dependent upon specific regulatory and
development targets, and then they are dependent upon sales thresholds.
In short, the devil is in the details.
Milestone payments, meaning not guaranteed payments.
The market is clearly forecasting that MannKind is not maximizing its
potential in this deal. As of the end of March, MannKind had accumulated
net loss carryforwards that has reached a total of almost $2.35
billion.
And add in the massive net loss caryforward loss of $2.35 billion.
Add it all up, and its not surprising this is not doing well. Not saying you wont make $$$$ at the end of the day, but its not all as great as it looks on paper.
MannKind got a raw deal on the partnership, hence why the stock is doing so terribly:
What seems to be the big kicker here is the split in profits. Sanofi
will retain 65% of the profits, and MannKind will receive 35% of the
profits, and they will share on that basis in the losses as well. The
agreement also shows that Sanofi agreed to advance to MannKind its share
of the collaboration’s expenses with a maximum limit of $175 million.
Thats a garbage deal right there. And there is more, according to that article: MannKind gets an upfront payment of $150 million from Sanofi. It is also
set to receive milestone payments of up to $775 million, but those
milestone payments are dependent upon specific regulatory and
development targets, and then they are dependent upon sales thresholds.
In short, the devil is in the details.
Milestone payments, meaning not guaranteed payments.
The market is clearly forecasting that MannKind is not maximizing its
potential in this deal. As of the end of March, MannKind had accumulated
net loss carryforwards that has reached a total of almost $2.35
billion.
And add in the massive net loss caryforward loss of $2.35 billion.
Add it all up, and its not surprising this is not doing well. Not saying you wont make $$$$ at the end of the day, but its not all as great as it looks on paper.
i'll wait to more details come out. Bottomline they got the best deal they could and the market for this product is huge even if they get 35%. They have other game changers including Technosphere. Al has over 1000 patents. Are you familiar with technosphere? No ones talked about forecasts etc., yet, also there may be more to the deal then expected. Its likely one piece of the puzzle. A lot of short interest has resulted in this, big boys need to cover.
MannKind got a raw deal on the partnership, hence why the stock is doing so terribly:
What seems to be the big kicker here is the split in profits. Sanofi
will retain 65% of the profits, and MannKind will receive 35% of the
profits, and they will share on that basis in the losses as well. The
agreement also shows that Sanofi agreed to advance to MannKind its share
of the collaboration’s expenses with a maximum limit of $175 million.
Thats a garbage deal right there. And there is more, according to that article: MannKind gets an upfront payment of $150 million from Sanofi. It is also
set to receive milestone payments of up to $775 million, but those
milestone payments are dependent upon specific regulatory and
development targets, and then they are dependent upon sales thresholds.
In short, the devil is in the details.
Milestone payments, meaning not guaranteed payments.
The market is clearly forecasting that MannKind is not maximizing its
potential in this deal. As of the end of March, MannKind had accumulated
net loss carryforwards that has reached a total of almost $2.35
billion.
And add in the massive net loss caryforward loss of $2.35 billion.
Add it all up, and its not surprising this is not doing well. Not saying you wont make $$$$ at the end of the day, but its not all as great as it looks on paper.
i'll wait to more details come out. Bottomline they got the best deal they could and the market for this product is huge even if they get 35%. They have other game changers including Technosphere. Al has over 1000 patents. Are you familiar with technosphere? No ones talked about forecasts etc., yet, also there may be more to the deal then expected. Its likely one piece of the puzzle. A lot of short interest has resulted in this, big boys need to cover.
Hey Louis_IV, I have invested around 4K in mnkd at 8.06. You said stock is constantly being manipulated? Can you give me some insight on this? And on how you think this company is gonna do for the future? Totally agree with positive news, fda approval, best deal possible but stock is has been declining. Shorts need to cover? whats the deal? thanks
0
Hey Louis_IV, I have invested around 4K in mnkd at 8.06. You said stock is constantly being manipulated? Can you give me some insight on this? And on how you think this company is gonna do for the future? Totally agree with positive news, fda approval, best deal possible but stock is has been declining. Shorts need to cover? whats the deal? thanks
Hey Louis_IV, I have invested around 4K in mnkd at 8.06. You said stock is constantly being manipulated? Can you give me some insight on this? And on how you think this company is gonna do for the future? Totally agree with positive news, fda approval, best deal possible but stock is has been declining. Shorts need to cover? whats the deal? thanks
If I knew all there was to know on this I would have sold at $11 and bought back in down here. I have a ton of this stock. As you said, everything has went as we hoped, positive ADCOM, FDA Approval, a great Diabetic Sales Partner w/ Sanofi having global experience.
People will twist this any way they want and say "MNKD got a bad deal", or the "Balance Sheet is bloated" but for some reason they are able to run the price up and then tear it down by shorting the hell out of it and then run it up again. The stock has a ton of market interest. Cramer and his cronie Adam Fartstain are always yammering about and just recently Cramer started to promote it, once he did it tanked heavily.
I believe the price is being manipulated in ways where the big firms are able to short and knock it down so much then buy back in and force it up buying big shares.
I never expected this. Been in awhile. I was buying in the 4s and 5s, sold all of that awhile back and made some decent money. Bought in again in 4s and 5s bad added a bunch after approval and now sit in 7.5 range per share.
I'll be adding again soon if it drops. I freed up some cash. Made a few bucks on ICPT the other day after runup. Its taken a lot out of me owning this one. I want to buy more but have been holding back because it still seems like it could fall.
I feel like there is more to this then meets the eye and at some point its going to fly on some type of news.
In the end I believe in Al Mann and what he has done with companies in the past, usually sells them and then starts something new. He's had MNKD for awhile. I believe in Afrezza and the Technosphere application. Al Mann has over 1000 patents. Sales partner is great, and will get us out globally once approved in other countries.
I cant explain the drop in certainty, I just know its unwarranted and based on what I know and what I believe this could be its a BUY in my book and I'm going with the facts I know.
0
Quote Originally Posted by PoeticJustice:
Hey Louis_IV, I have invested around 4K in mnkd at 8.06. You said stock is constantly being manipulated? Can you give me some insight on this? And on how you think this company is gonna do for the future? Totally agree with positive news, fda approval, best deal possible but stock is has been declining. Shorts need to cover? whats the deal? thanks
If I knew all there was to know on this I would have sold at $11 and bought back in down here. I have a ton of this stock. As you said, everything has went as we hoped, positive ADCOM, FDA Approval, a great Diabetic Sales Partner w/ Sanofi having global experience.
People will twist this any way they want and say "MNKD got a bad deal", or the "Balance Sheet is bloated" but for some reason they are able to run the price up and then tear it down by shorting the hell out of it and then run it up again. The stock has a ton of market interest. Cramer and his cronie Adam Fartstain are always yammering about and just recently Cramer started to promote it, once he did it tanked heavily.
I believe the price is being manipulated in ways where the big firms are able to short and knock it down so much then buy back in and force it up buying big shares.
I never expected this. Been in awhile. I was buying in the 4s and 5s, sold all of that awhile back and made some decent money. Bought in again in 4s and 5s bad added a bunch after approval and now sit in 7.5 range per share.
I'll be adding again soon if it drops. I freed up some cash. Made a few bucks on ICPT the other day after runup. Its taken a lot out of me owning this one. I want to buy more but have been holding back because it still seems like it could fall.
I feel like there is more to this then meets the eye and at some point its going to fly on some type of news.
In the end I believe in Al Mann and what he has done with companies in the past, usually sells them and then starts something new. He's had MNKD for awhile. I believe in Afrezza and the Technosphere application. Al Mann has over 1000 patents. Sales partner is great, and will get us out globally once approved in other countries.
I cant explain the drop in certainty, I just know its unwarranted and based on what I know and what I believe this could be its a BUY in my book and I'm going with the facts I know.
Thanks for responding. I agree..this drug is really amazing, and if it hits below 7, im thinking of buying more. Can you friend request me? Was wondering what other stocks you have invested in.
ps: your mlb picks are awesome lol, 6-0 run?
0
Thanks for responding. I agree..this drug is really amazing, and if it hits below 7, im thinking of buying more. Can you friend request me? Was wondering what other stocks you have invested in.
thanks for the update, we that own were not aware. Games being played so ALL THESES SHORTS get their money back that shorted awhile back at 5 and 6. it is what it is. Company has done exactly what I hoped in terms of product approval and partner
0
Quote Originally Posted by icemantbi:
oof... stock is at $6.80 right now.. yikes.
thanks for the update, we that own were not aware. Games being played so ALL THESES SHORTS get their money back that shorted awhile back at 5 and 6. it is what it is. Company has done exactly what I hoped in terms of product approval and partner
added 500 shares @6.87. I want more but not blowing my whole load yet, could drop further. Just don't know. I'll work my way down if I have too. This will lower my dollar average cost a little. It appears the second half of the day has shown a small sign of hope.
On Yahoo Stocktwits my username is BlackjackAces in case folks are in the tweet boards there chatting stocks. Its not twitter.
0
added 500 shares @6.87. I want more but not blowing my whole load yet, could drop further. Just don't know. I'll work my way down if I have too. This will lower my dollar average cost a little. It appears the second half of the day has shown a small sign of hope.
On Yahoo Stocktwits my username is BlackjackAces in case folks are in the tweet boards there chatting stocks. Its not twitter.
If you choose to make use of any information on this website including online sports betting services from any websites that may be featured on
this website, we strongly recommend that you carefully check your local laws before doing so.It is your sole responsibility to understand your local laws and observe them strictly.Covers does not provide
any advice or guidance as to the legality of online sports betting or other online gambling activities within your jurisdiction and you are responsible for complying with laws that are applicable to you in
your relevant locality.Covers disclaims all liability associated with your use of this website and use of any information contained on it.As a condition of using this website, you agree to hold the owner
of this website harmless from any claims arising from your use of any services on any third party website that may be featured by Covers.
MNKD
Hot Forum Topics
